Teduglutide biosimilar - PEPGENE
Alternative Names: PG-003 - PEPGENELatest Information Update: 10 Feb 2023
At a glance
- Originator PEPGENE
- Class Anti-inflammatories; Peptides
- Mechanism of Action Glucagon-like peptide 2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Short bowel syndrome
Most Recent Events
- 04 Jan 2023 Preclinical trials in Short bowel syndrome in South Korea (SC) (PEPGENE pipeline, January 2023)
- 04 Jan 2023 PEPGENE files an IND application for Short bowel syndrome in South Korea (PEPGENE pipeline, January 2023)
- 04 Jan 2023 PEPGENE plans a phase I trial in Short bowel syndrome (SC) in 2023 (PEPGENE pipeline, January 2023)